Pallavi Rastogi is an Oncologist and a Hematologist in Paoli, Pennsylvania. Dr. Rastogi is rated as an Advanced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. Her top areas of expertise are Paget Disease of the Breast, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration.

Sandra Urtishak is a Hematologist Oncology specialist and a Palliative Medicine provider in Paoli, Pennsylvania. Dr. Urtishak is rated as an Experienced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Laryngeal Cancer, and Throat Cancer.

Michael Dabrow is a Hematologist Oncology specialist and a Hematologist in Bryn Mawr, Pennsylvania. Dr. Dabrow is rated as an Experienced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. His top areas of expertise are Pleuropulmonary Blastoma, Breast Cancer, Melanoma of the Eye, and Familial Colorectal Cancer.

Christine Szarka is a Hematologist Oncology specialist and a Hematologist in Paoli, Pennsylvania. Dr. Szarka is rated as an Experienced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Childhood Iron Deficiency Anemia, and Pleuropulmonary Blastoma.

Robert Kaplan is a Hematologist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Kaplan is rated as a Distinguished provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. His top areas of expertise are Atypical Hemolytic Uremic Syndrome (aHUS), D-Plus Hemolytic Uremic Syndrome, Hemolytic-Uremic Syndrome, and Deep Vein Thrombosis.

Ibrahim Sbeitan, MD, specializes in hematology oncology and is board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. He practices at UPMC Hillman Cancer Center. Dr. Sbeitan received his medical degree from the University of Jordan School of Medicine and completed his residency at Gundersen Medical Foundation in La Crosse, Wisconsin, followed by a fellowship at the University of Pittsburgh School of Medicine. Dr. Sbeitan is rated as an Advanced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. His top areas of expertise are Chronic Familial Neutropenia, Familial Colorectal Cancer, Lynch Syndrome, and Colorectal Cancer.

Adam Cuker is a Hematologist in Philadelphia, Pennsylvania. Dr. Cuker is rated as an Advanced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. His top areas of expertise are Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Splenectomy, and Knee Replacement. Dr. Cuker is currently accepting new patients.

Theresa Mchugh is a Hematologist Oncology specialist and a Hematologist in Wynewood, Pennsylvania. Dr. Mchugh is rated as an Advanced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Hemolytic-Uremic Syndrome, and D-Plus Hemolytic Uremic Syndrome.

Sanaa Rizk is a Hematologist in Philadelphia, Pennsylvania. Dr. Rizk is rated as an Advanced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. Her top areas of expertise are Sickle Cell Disease, Thrombocytopenia, Paroxysmal Cold Hemoglobinuria, and Anemia.

Bernard Kaplan is a Pediatric Nephrologist in Philadelphia, Pennsylvania. Dr. Kaplan is rated as an Advanced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. His top areas of expertise are D-Plus Hemolytic Uremic Syndrome, D-Minus Hemolytic Uremic Syndrome, Hemolytic-Uremic Syndrome, and Atypical Hemolytic Uremic Syndrome (aHUS).

Arunkumar Sanjeevi is a Hematologist Oncology specialist and a Hematologist in Bethel Park, Pennsylvania. Dr. Sanjeevi is rated as an Advanced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. His top areas of expertise are Thrombocytopenia, Monoclonal Gammopathy of Undetermined Significance (MGUS), Paget Disease of the Breast, and Colorectal Cancer. Dr. Sanjeevi is currently accepting new patients.

Lawrence Copelovitch is a Pediatric Nephrologist and a Pediatrics provider in Philadelphia, Pennsylvania. Dr. Copelovitch is rated as an Advanced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. His top areas of expertise are Kidney Stones, Dent Disease, Nephrocalcinosis, Lithotripsy, and Kidney Transplant.

Beth Piraino is a Nephrologist in Pittsburgh, Pennsylvania. Dr. Piraino is rated as an Experienced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. Her top areas of expertise are Secondary Peritonitis, Chronic Kidney Disease, End-Stage Renal Disease (ESRD), and Atypical Hemolytic Uremic Syndrome (aHUS).

James Johnston is a Nephrologist in Pittsburgh, Pennsylvania. Dr. Johnston is rated as an Experienced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. His top areas of expertise are Atypical Hemolytic Uremic Syndrome (aHUS), D-Plus Hemolytic Uremic Syndrome, Hemolytic-Uremic Syndrome, and End-Stage Renal Disease (ESRD).

Shiva Kumar R. Mukkamalla, MD, MPH, specializes in hematology oncology and is board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. He practices at UPMC Hillman Cancer Center - Punxsutawney Area Hospital and IRMC Cancer Center in Partnership with UPMC Hillman Cancer Center. Dr. Mukkamalla completed his medical degree at Osmania Medical College, residency at Queens Hospital Center, and fellowship at Roger Williams Medical Center. Dr. Mukkamalla is rated as an Experienced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Follicular Lymphoma.

Roy E. Smith, MD, is a professor of medicine at the University of Pittsburgh School of Medicine in the Division of Hematology/Oncology. Dr Smith specializes in bleeding and thrombotic disorders, Rare Homologic Diseases, Chronic Leukemia and Myelodyplasia. Dr. Smith is board-certified in internal medicine, medical oncology, and hematology. He received his medical degree from The Ohio State University, Columbus, and his Master of Science degree from the University of Wisconsin, College of Medicine, Madison. He completed his residency in medical oncology and his fellowship in hematology oncology, both at The Ohio State University. He is the former director of the Ohio State University Hospital's Special Coagulation Laboratory and its Hemophilia Center. He presently serves as chairman of the Central Investigational Review Board for the Cancer Therapeutics and Development branch of the National Cancer Institute and has served on the Peripheral and Central Nervous System Drug Advisory Committee and the Oncologic Drug Advisory Committee of the FDA. Dr. Smith serves as the co-chair of the Anticoagulation Task Force for the Presbyterian Hospital and its affiliates and chair of the Anticoagulation Working Group of the system-wide P and T committee. Dr. Smith is a member of the American Society of Hematology, the American Society of Clinical Oncology, the Society for Scientific Exploration, The International Society of Thrombosis and Hemostasis, the American Medical Association and the American Society for Apheresis, and the American College of Chest Physicians. He is a Fellow of the American College of Physicians and the International Academy of Clinical and Applied Thrombosis and Hemostasis. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. His top areas of expertise are Venous Thromboembolism (VTE), Acute Hepatic Porphyria (AHP), Shwartzman Phenomenon, and Porphyria.

Charles Geyer, MD, specializes in breast medical oncology and is certified in medical oncology and internal medicine by the American Board of Internal Medicine. He practices at the UPMC Magee Womens Hospital. He completed his medical degree at Texas Tech University Health Science Center, residency at Baylor College of Medicine, chief residency at Baylor College of Medicine and medical oncology fellowship at Baylor College of Medicine. Dr. Geyer is rated as an Experienced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Febrile Neutropenia, and Menopause.

Naeem Latif is a Hematologist Oncology provider in Lititz, Pennsylvania. Dr. Latif is rated as an Experienced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. His top areas of expertise are Paget Disease of the Breast, Colorectal Cancer, Familial Pancreatic Cancer, and Familial Colorectal Cancer. Dr. Latif is currently accepting new patients.

Cindylou Connell, MD, specializes in medical oncology and is board-certified in medical oncology by the American Board of Internal Medicine. She practices at UPMC Hillman Cancer Center-Pinnacle and is affiliated with UPMC Northwest, UPMC Carlisle, UPMC West Shore, UPMC Community Osteopathic, and UPMC Pinnacle Harrisburg. Dr. Connell completed her medical degree at The Ohio State University College of Medicine, residency program at Ohio State University Hospitals, and fellowship program at the University of Michigan Hospitals. Dr. Connell is rated as an Experienced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Colorectal Cancer, Adenoid Cystic Carcinoma, and Bone Marrow Aspiration.

Sarah McElroy, DO, specializes in family medicine and is certified in family medicine/OMT by the American Osteopathic Board of Family Physicians. She practices at UPMC Susquehanna Health, Family Medicine at Lock Haven and is affiliated with UPMC Williamsport and UPMC Lock Haven. She completed her residency at Williamsport Family Medicine Residency Center and medical degree at Philadelphia College of Osteopathic Medicine. Dr. Mcelroy is rated as an Experienced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. Her top areas of expertise are Hyperlipidemia Type 3, Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), and Hypertension.